About GLS Pharma Limited
Data last updated:
GLS Pharma Limited is a public limited company based in Seri Lingampally, Telangana, India, a subsidiary of Aurobindo Pharma Ltd. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 01 September 2004, the company has been in operation for over 22 years.
Registered with ROC Hyderabad under CIN U24239TS2004PLC184306.
Capital: an authorised share capital of ₹1.3 Cr and a paid-up capital of ₹1.2 Cr. Formerly known as Gls Pharma Private Limited and Getwell Life Sciences India Private Limited. It is led by directors including Srinivasa Ramachandra Rao Ilapakurthy and Pendem Harish Babu.
Last AGM: 22 September 2025. Financial statements filed for year ended 31 March 2025. Office: Seri Lingampally, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹36.08 Cr, reflecting significant growth compared to the previous year.
The company has a workforce of approximately 116 employees as per the latest available data. It operates as a subsidiary of Aurobindo Pharma Ltd.
The company is associated with 1 brand - Gls Pharma. As per MCA filings, the company has open charges of ₹2 Cr and satisfied charges of ₹15.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glspharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressGalaxy Floors 22 – 24 Plot No. 1 Survey No. 83/1, Hyderabad Knowledge City Raidurg Panmaktha, Seri Lingampally, Telangana, India – 500032
- IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of GLS Pharma
GLS Pharma has undergone 2 name changes throughout its history. The company was previously known as Gls Pharma Private Limited, and Getwell Life Sciences India Private Limited.. The current legal name is Gls Pharma Limited.
| Company Name | Status |
|---|---|
| GLS Pharma Limited | Current |
| Gls Pharma Private Limited | Previous |
| Getwell Life Sciences India Private Limited. | Previous |
CIN History of GLS Pharma
GLS Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24239TS2004PLC184306, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TS2004PLC184306 | Current |
| U24239DL2004PTC128728 | Previous |
| U24239DL2004PLC128728 | Previous |
Associated Brands with GLS Pharma
GLS Pharma operates one associated brand: GLS Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology APIs and anti-cancer products are manufactured. | glspharma.com |
Business Activity of GLS Pharma
GLS Pharma operates primarily in the manufacturing sector. 2 business activities are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| Locked | Manufacturing | Locked | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Detailed business activity records for GLS Pharma Limited
Activity codes and each activity's share of turnover are in the company report.
- Activity group codes
- Detailed activity codes
- Turnover contribution
Verified entity values are shown only after access is granted.
Auditor Details of GLS Pharma
GLS Pharma Limited is audited by G P M & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G P M & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for GLS Pharma Limited
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of GLS Pharma Limited
GLS Pharma has 3 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Ramachandra Rao Ilapakurthy Also directs: Auro Pharma Limited, Lyfius Pharma Private Limited | Director | 15 Dec 2023 | 2 Years 9 Months | Current |
| Pendem Harish Babu Also directs: Auro Pharma Limited | Additional Director | 25 Oct 2025 | 0 Years 11 Months | Current |
| Ravikiran Namburi | Director | 20 Sep 2024 | 2 Years 0 Months | Current |
Financials of GLS Pharma Limited FY 2025 filings available
GLS Pharma Limited reported revenue of ₹36.08 Cr (up 13862.30% YoY) for FY 2023.
Ten-year financial statements for GLS Pharma Limited
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of GLS Pharma
Shareholding and ownership data for GLS Pharma Limited
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of GLS Pharma
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Sep 2022 | Canara Bank | ₹2 Cr | Open |
| 30 Aug 2021 | Canara Bank | ₹2.5 Cr | Satisfied |
| 15 Dec 2020 | Syndicate Bank | ₹96 Lakh | Satisfied |
| 14 Dec 2020 | Canara Bank | ₹80 Lakh | Satisfied |
| 30 Sep 2015 | Syndicate Bank | ₹7.97 Cr | Satisfied |
Total charge records: 8 View all charges
Employees and EPFO Compliance at GLS Pharma
GLS Pharma Limited has a workforce of 116 employees as of Apr 03, 2024.
Employee and EPFO history for GLS Pharma Limited
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of GLS Pharma
GST registrations and filing compliance for GLS Pharma Limited
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for GLS Pharma
Credit ratings, litigation, and regulatory alerts for GLS Pharma Limited
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by GLS Pharma
MSME payment history for GLS Pharma Limited
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of GLS Pharma
Corporate group structure for GLS Pharma Limited
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of GLS Pharma
MCA filings and documents for GLS Pharma Limited
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on GLS Pharma
Frequently Asked Questions about GLS Pharma Limited
GLS Pharma is an active public limited company in the pharma sector based in Seri Lingampally, Telangana, India. It was incorporated on 01 September 2004 (22+ years old) and is registered under CIN U24239TS2004PLC184306. The company has 116 employees.
GLS Pharma reported revenue of ₹36.08 Cr for FY 2023 (up 13862.30% YoY).
The current directors of GLS Pharma are:
- Srinivasa Ramachandra Rao Ilapakurthy - Director
- Pendem Harish Babu - Additional Director
- Ravikiran Namburi - Director
The primary industry of GLS Pharma is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
GLS Pharma can be reached at the registered office: Galaxy Floors 22 – 24 Plot No. 1 Survey No. 831, Hyderabad Knowledge City Raidurg Panmaktha, Seri Lingampally, Telangana, India – 500032, or through the website glspharma.com.
The authorised capital is ₹1.3 Cr, and the paid-up capital is ₹1.2 Cr.